A flexible system has been developed for studying the structures of complexes of HIV-1 reverse transcriptase (RT) with nucleic acid template- primers and inhibitors at 2.8 Angstrom resolution. We have thus far determined the structure of a ternary complex of HIV-1 RT with a monoclonal antibody Fab fragment (Fab28) and a 19 base/18 base dsDNA (19/18 dsDNA) template-primer at 3.5 Angstrom resolution and are refining the structure at 2.8 Angstrom resolution. The crystal form that we are using is particularly advantageous because 1) it is providing the first atomic structure of any polymerase bound to nucleic acid in a mode relevant for polymerization, and 2) complexes containing antiviral compounds, different template-primers, and HIV-1 RT mutants can be studied by the straightforward difference Fourier method. Since only the altered portion of the structure needs to be solved, all of the proposed studies can be done with relative facility. Specifically, using the HIV-1 RT/Fab28 crystals, we will solve and refine the structures of variants that contain three different nucleic acid template-primers (19/18 dsDNA, 30/18 dsDNA, and 30/18 RNA/DNA). These RT/Fab/template-primer complexes will be the reference structures for all of the other determinations. We will determine the structures of the RT/Fab/DNA crystals containing triphosphate forms of the nucleoside inhibitors AZT and ddI, using both wild-type and nucleoside-resistant HIV- 1 RT mutants. The structure of an HIV-1 /HIV-2 chimera in which the HIV-2 polymerase active site has been transplanted onto HIV-1 RT will be determined, thus permitting examination of the structure of the HIV-2 RT active site. The structural information gained from this work will be helpful in understanding the molecular mechanisms of DNA polymerization, RT inhibition, and development of resistance to nucleoside inhibitors. The detailed stereochemical description of nucleoside triphosphate inhibitor complexes with HIV-1 RT should be valuable in the design and refinement of antiviral agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI027690-06
Application #
2064030
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1988-11-01
Project End
1998-10-31
Budget Start
1993-11-01
Budget End
1994-10-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
Organized Research Units
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Lee, Won-Gil; Frey, Kathleen M; Gallardo-Macias, Ricardo et al. (2015) Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 25:4824-7
Abram, Michael E; Ferris, Andrea L; Das, Kalyan et al. (2014) Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication. J Virol 88:7589-601
Vijayan, R S K; Arnold, Eddy; Das, Kalyan (2014) Molecular dynamics study of HIV-1 RT-DNA-nevirapine complexes explains NNRTI inhibition and resistance by connection mutations. Proteins 82:815-29
Bauman, Joseph D; Patel, Disha; Dharia, Chhaya et al. (2013) Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening. J Med Chem 56:2738-46
Bollini, Mariela; Frey, Kathleen M; Cisneros, José A et al. (2013) Extension into the entrance channel of HIV-1 reverse transcriptase--crystallography and enhanced solubility. Bioorg Med Chem Lett 23:5209-12
Chung, Suhman; Himmel, Daniel M; Jiang, Jian-Kang et al. (2011) Synthesis, activity, and structural analysis of novel ýý-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem 54:4462-73
Frenkel, Yulia Volovik; Gallicchio, Emilio; Das, Kalyan et al. (2009) Molecular dynamics study of non-nucleoside reverse transcriptase inhibitor 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/rilpivirine) aggregates: correlation between amphiphilic properties of the drug an J Med Chem 52:5896-905
Das, Kalyan; Bandwar, Rajiv P; White, Kirsten L et al. (2009) Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem 284:35092-100
Dunn, Linda L; McWilliams, Mary Jane; Das, Kalyan et al. (2009) Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions. J Virol 83:12336-44
Himmel, Daniel M; Maegley, Karen A; Pauly, Tom A et al. (2009) Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site. Structure 17:1625-1635

Showing the most recent 10 out of 64 publications